Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Research and Markets: Menarini IMS Company Profile
August 31st, 2007
Research and Markets has announced the addition of Menarini IMS Company Profile to their offering. IMS Health's Company Profiles give you the authoritative insight into a company at a strategic and local level. Each individual IMS Company Profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the relative strengths and weaknesses of a company's business strategy. - Critical analyses provided by an in-house expert team - 90+ full in-depth company profiles covering all major pharmaceutical...
Source: Drug Week (2007-08-31)
|
